InstantGMP™ has announced a Spanish language translation of its website.
This initiative aims to help pharmaceutical, dietary supplement, and cannabis manufacturers in Spain, Mexico, and Latin America comply with both the Spanish pharmaceutical regulatory authority and international standards, including COFEPRIS GMP standards, EMA guidelines, and FDA requirements.
With this new website enhancement, InstantGMP helps bridge the compliance gap for Spanish-speaking markets. Pharmaceutical and supplement manufacturers in Spain must adhere to Spanish pharmaceutical regulations outlined in EudraLex Volume 4 and enforced by the AEMPS (Agencia Española de Medicamentos y Productos Sanitarios or Spanish Agency of Medicines and Medical Devices).
"With the launch of our Spanish-language website, we are reinforcing our commitment to making compliance more accessible for pharmaceutical and dietary supplement manufacturers in Spain, Mexico, and Latin America," said Dr. Richard Soltero, President of InstantGMP. "These regions have rapidly expanding regulated industries, and we recognize the need for digital solutions such as electronic batch records for manufacturers that help companies navigate complex regulatory landscapes while improving operational efficiency."
For more information:
InstantGMP
instantgmp.com/